Open AccessLigelizumab: A promising option on the horizon for the management of chronic spontaneous urticaria
Author(s) -
Kiran Godse,
Anant Patil,
Gauri Godse
Publication year - 2021
Publication title -
indian journal of drugs in dermatology
Language(s) - English
Resource type - Journals
ISSN - 2455-3972
DOI - 10.4103/ijdd.ijdd_33_20
Subject(s) - omalizumab , medicine , immunoglobulin e , antihistamine , chronic urticaria , monoclonal antibody , antibody , monoclonal , immunology